Keyphrases
Cystic Fibrosis
100%
Dry Powder Inhaler
100%
Inhalational
100%
Phoenix Dactylifera
100%
Date Palm
100%
Nanoaggregates
100%
Chitosan Nanoparticles
80%
Nanoparticles
60%
Lung
40%
Chitosan
40%
Pseudomonas Aeruginosa Biofilm
40%
Artificial Sputum Medium
40%
Route of Administration
20%
Antioxidant
20%
Recurring
20%
Drug Delivery
20%
Physical Properties
20%
Patient-centered
20%
Antibiotics
20%
Non-invasive Method
20%
Potential Treatments
20%
Bacterial Resistance
20%
Aerosolization
20%
In Vitro Aerosolization
20%
Emitted Dose
20%
Fine Particle Fraction
20%
Antimicrobial Activity
20%
Lung Disease
20%
Spherical Particles
20%
Local Delivery
20%
TEM Images
20%
Aerodynamics
20%
FTIR Study
20%
Biofilm Model
20%
Zetasizer
20%
Next Generation Impactor
20%
Natural Antibacterial
20%
Date Seed Powder
20%
Date Palm Extract
20%
High Encapsulation Efficiency
20%
XRD Study
20%
Antibacterial Biofilm
20%
Date Extract
20%
Biofilm Characteristics
20%
Chitosan Powder
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chitosan
100%
Cystic Fibrosis
100%
Dry Powder Inhaler
100%
Nanoparticle
100%
Date (Fruit)
100%
Antiinfective Agent
42%
Pseudomonas aeruginosa
28%
Antioxidant
14%
Antibiotics
14%
Antibiotic Resistance
14%
Antimicrobial Agent
14%
Route of Administration
14%
Lung Disease
14%